Navigation Links
PI presents safety results in Neuralstem ALS Stem Cell Trial
Date:4/12/2011

ROCKVILLE, Maryland, April 12, 2011 Neuralstem, Inc. (NYSE Amex: CUR) announced that Eva Feldman, M.D., Ph.D., Principal Investigator of the Phase I safety trial of Neuralstem's human spinal cord stem cells (HSSC's) in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), and unpaid Neuralstem consultant, presented interim safety data on the first nine patients. Dr. Feldman reported yesterday at the American Academy of Neurology (AAN American Academy of Neurology (AAN) Annual Meeting (http://www.aan.com/go/am11) that all nine ALS patients remain alive and that there were no unresolved serious adverse reactions related to surgery. Of the three ambulatory patients who were treated, all remain ambulatory with no serious adverse events secondary to surgery.

"We are delighted. This data demonstrates it is feasible to transplant stem cells directly into the spinal cord of patients with ALS using the procedure and device we developed for this trial, " commented Dr. Feldman who is also Director of the A. Alfred Taubman Medical Research Institute and Director of Research of the ALS Clinic at the University of Michigan Health System. "This groundbreaking work has never been done before, and we are thrilled that it can be done safely."

In this group of nine male patients, ranging in age from 37-to-66 years, with ALS duration at the time of surgery ranging from 1-to-12 years, the first six were non-ambulatory with complete paralysis. Of these, four out of six experienced transient neuropathic pain in the spinal dermatomes near the injected area within 24 hours of the procedure, which resolved with no treatment. Three out of the six experienced adverse events secondary to immunosuppression, which were resolved via dose adjustment in two cases and discontinuance in the third. One patient experienced a pulmonary embolism 19 days post-surgery secondary to an iliac vein thrombosis, unlikely related to the cell
'/>"/>

Contact: Deanne Eagle
deanneeagle@gmail.com
917-837-5866
Neuralstem, Inc.
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Alfred B. Knight, M.D., Scott & White Healthcare, presents at 8th Annual World Health Care Congress
2. Cancer surgery society presents top honor to Kimberly Duchossois
3. Euthymics presents phase II data for EB-1010 in major depression at ACNP annual meeting
4. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
5. Professor Zvi Ram presents phase III recurrent glioblastoma survival and quality of life data from the first pivotal study of the NovoTTF-100A at 15th Annual Society for Neuro-Oncology Scientific Meeting
6. AAPS presents awards to exemplary researchers
7. Governor presents UH researcher with grant for cardiac device
8. Onconova Therapeutics presents new data demonstrating radioprotection by Ex-RAD at RRS annual meeting
9. APA presents latest research on same-sex marriage at annual convention in San Diego
10. AOSSM presents prestigious research awards at annual meeting
11. Pfizer Hemophilia presents new data at the World Federation of Hemophilia 2010 Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... ... and the growing number of individuals who remain undiagnosed, treatment options for patients ... shy away from traditional CPAP therapy due to its overall lack of comfort ...
(Date:7/30/2015)... ... July 30, 2015 , ... Dale Sky Jones, Executive Chancellor of ... at the International Cannabis Professionals Expo held at the Caribe Royal All Suites Hotel ... Cannabis Professionals Expo is the largest medical cannabis expo in the country and ...
(Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... The Venetian on Grace Bay in the ... Guests who stay at the Venetian will save 40% on their stay while enjoying some ... always quiet in the Turks & Caicos, providing a chance to reconnect with loved ones ...
(Date:7/30/2015)... Ferry, New York (PRWEB) , ... July 31, 2015 , ... ... Barack Obama’s call to action by asking community members to contribute to the College’s ... on, “Helping more of our young people stay on track. Providing the support they ...
(Date:7/30/2015)... ... July 30, 2015 , ... As more hospitals across ... of recruiting patients becomes a serious challenge. Because of growing competition, it is ... within the local community. , The team at Wound Care Advantage ...
Breaking Medicine News(10 mins):Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4
... System scheduled to start this month.BERKELEY HEIGHTS, N.J., ... formed by Authentidate Holding Corp. (Nasdaq: ... ECSL) to provide remote patient monitoring telehealth systems ... chronic conditions announced today that its remote patient ...
... Four conferences scheduled for Wayne ... Adult Well-Being Services will host four conferences in ... vital information and critical support to persons caring for ... on issues ranging from legal and financial concerns to ...
... a fully human monoclonal antibody that inhibits the activity ... to reduce pancreatic cancer cells in early testing, according ... a journal of the American Association for Cancer Research. ... and less than 4 percent of the 200,000 patients ...
... Medical device industry leaders, lawmakers, and government ... of the Medical Device Manufacturers Association (MDMA) June ... Washington, D.C. (Logo: ... bring together executives from innovative entrepreneurial medical technology ...
... "Making the Stroke Connection" will take place on Friday, May ... 12 p.m. Activities include a stroke survivor/caregiver forum, a CME/CEU ... an awards celebration lunch from 12:30 2 p.m., hosted ... Milton Resident Margaret Kelly-Hayes, EdD, RN, FAAN, FAHA, CRRN, is ...
... Mass., April 14 Intrinsic Therapeutics, Inc. announced today ... Barricaid(R) anular prosthesis for use in reconstructing soft tissues ... approval to distribute the Barricaid throughout the European Union ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090414/NE98588LOGO ...
Cached Medicine News:Health News:ExpressMD(TM) Solutions' Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA 2Health News:ExpressMD(TM) Solutions' Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA 3Health News:ExpressMD(TM) Solutions' Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA 4Health News:ExpressMD(TM) Solutions' Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA 5Health News:Adult Well-Being Services Offers Valuable Resources for Caregivers 2Health News:Adult Well-Being Services Offers Valuable Resources for Caregivers 3Health News:AHRQ Director Carolyn Clancy and Dr. Mark McClellan to Address Device Executives 2009 MDMA Annual Meeting 2Health News:Milton resident receives the Helen B. Spaulding Community Conscience Award 2Health News:Intrinsic Therapeutics Announces CE Mark for Barricaid Anular Prosthesis 2
(Date:7/30/2015)... July 30, 2015 ... report with market overview, trends, DRO analysis, ... analysis, recent developments, competitive scenario and top ... Insight: Biosensors Market Development and Demand Forecast ... http://photos.prnewswire.com/prnh/20150727/756778 ) Explore more about ...
(Date:7/30/2015)... 2015 Vermillion, Inc. (VRML), a ... announced today it will report its second ... close on Thursday, August 13, 2015, followed ... at 4:30pm Eastern.Conference Call and Webcast:  ... Pacific  Domestic: , 888-430-8691International: ...
(Date:7/30/2015)... , July 30, 2015 What ... ? Which areas are going to grow at the ... you potential revenues to 2025, assessing data, trends, opportunities ... provides 176 tables, charts, and graphs. Discover the ... market prospects. Our new study lets you assess forecasted ...
Breaking Medicine Technology:Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6
... Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced ... private company that holds certain rights and know-how to poloxamer-based ... the target company. About the ... target company contemplate an all-stock acquisition by merger. Other than ...
... 2011 Amarin Corporation plc (Nasdaq: AMRN ... focus on cardiovascular disease, today announced that, in connection ... Depositary Shares ("ADSs"), the underwriters of the offering have ... an aggregate of 1,800,000 additional ADSs to cover over-allotments. ...
Cached Medicine Technology:ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 2ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 3ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 4ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 5Amarin Announces Underwriters' Exercise of Over-Allotment Option 2Amarin Announces Underwriters' Exercise of Over-Allotment Option 3Amarin Announces Underwriters' Exercise of Over-Allotment Option 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: